Boehringer Ingelheim

Looking for 'external innovation,' Boehringer Ingelheim reserves $500M+ for new Shanghai hub
Looking for 'external innovation,' Boehringer Ingelheim reserves $500M+ for new Shanghai hub
Endpoints
China
Shanghai
Boehringer Ingelheim
drug manufacturing
Flag link:
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Beckers Hospital Review
Big Pharma
drug development
antibiotics
innovation
Eli Lilly
Pfizer
Merck
Boehringer Ingelheim
Bayer
CARB-X
Flag link:
Boehringer debuts IPF songwriting contest with MLB player-turned-singer Bernie Williams
Boehringer debuts IPF songwriting contest with MLB player-turned-singer Bernie Williams
Fierce Pharma
Boehringer Ingelheim
IPF
drug marketing
Flag link:
Boehringer Ingelheim nabs new US president and CEO
Boehringer Ingelheim nabs new US president and CEO
Endpoints
Boehringer Ingelheim
Pharma CEOs
Jean-Michel Boers
Flag link:
Boehringer launches open innovation project for work-at-home scientists
Boehringer launches open innovation project for work-at-home scientists
Pharmaforum
Boehringer Ingelheim
R&D
pandemic
COVID-19
opnMe
Flag link:
Boehringer Ingelheim collaborates with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy
Boehringer Ingelheim collaborates with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy
Pharmaceutical Business Review
Boehringer Ingelheim
CDR-Life
antibody fragments
geographic atrophy
R&D
Flag link:
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline
Xconomy
Northern Biologics
Boehringer Ingelheim
cancer immunology
Flag link:
Boehringer Ingelheim adds second AI partner in a month
Boehringer Ingelheim adds second AI partner in a month
Endpoints
Boehringer Ingelheim
artificial intelligence
BERG
Bayesian AI
biomarkers
Crohn's Disease
inflammatory bowel disease
Flag link:
The top pharma companies in social media
The top pharma companies in social media
Fierce Pharma
social media
Boehringer Ingelheim
AbbVie
GSK
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Flag link:
Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?
Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?
Fierce Biotech
COVID-19
pandemic
Merck
Januvia
diabetes
Boehringer Ingelheim
Eli Lilly
Tradjenta
Flag link:
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
Flag link:
FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod
FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
type 1 diabetes
diabetes
empagliflozin
Flag link:
Lilly and Boehringer's Jardiance, chasing AZ, nabs speedy FDA review in kidney disease
Lilly and Boehringer's Jardiance, chasing AZ, nabs speedy FDA review in kidney disease
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
AstraZeneca
FDA
Jardiance
kidney disease
Flag link:
Boehringer Ingelheim's Ofev nabs FDA nod for expanded use in rare lung disease
Boehringer Ingelheim's Ofev nabs FDA nod for expanded use in rare lung disease
Fierce Pharma
Boehringer Ingelheim
IPF
Ofev
FDA
ILD
Flag link:
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Fierce Pharma
COVID-19
coronaviruses
Roche
GSK
Bristol-Myers Squibb
Sanofi
Boehringer Ingelheim
Amgen
Biogen
Mylan
Flag link:
Boehringer bags CHMP backing for Ofev in rare lung disease
Boehringer bags CHMP backing for Ofev in rare lung disease
Pharmaforum
Boehringer Ingelheim
Ofev
Europe
CHMP
scleroderma
Flag link:
Boehringer Ingelheim enters discovery stage collaboration with Trutino Biosciences
Boehringer Ingelheim enters discovery stage collaboration with Trutino Biosciences
Pharmaceutical Business Review
Boehringer Ingelheim
Trutino Biosciences
R&D
Flag link:
FDA Approves Eli Lilly's and Boehringer Ingelheim Pharmaceuticals' Triple-Combination Diabetes Drug Trijardy XR
FDA Approves Eli Lilly's and Boehringer Ingelheim Pharmaceuticals' Triple-Combination Diabetes Drug Trijardy XR
Motley Fool
FDA
Eli Lilly
Boehringer Ingelheim
Trijardy XR
Jardiance
Tradjenta
metformin
diabetes
Flag link:
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis
Motley Fool
AbbVie
Boehringer Ingelheim
Skyrizi
Novartis
Cosentyx
psoriasis
Flag link:
Boehringer Ingelheim inks 'Singapore's largest biotech deal,' promising $1B each for a suite of anti-fibrotic IL-11 drugs
Boehringer Ingelheim inks 'Singapore's largest biotech deal,' promising $1B each for a suite of anti-fibrotic IL-11 drugs
Endpoints
Boehringer Ingelheim
Singapore
fibrotic disease
Flag link:

Pages